Plato Investment Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176K Sell
2,773
-7,685
-73% -$505K 0.01% 411
2026
Q1
$745K Hold
10,458
– – 0.05% 303
2025
Q4
$862K Hold
10,458
– – 0.06% 286
2025
Q3
$779K Buy
10,458
+1,537
+17% +$115K 0.05% 294
2025
Q2
$658K Buy
8,921
+6,612
+286% +$460K 0.05% 313
2025
Q1
$188K Buy
2,309
+45
+2% +$3.87K 0.02% 399
2024
Q4
$178K Hold
2,264
– – 0.01% 418
2024
Q3
$212K Hold
2,264
– – 0.02% 381
2024
Q2
$176K Hold
2,264
– – 0.02% 344
2024
Q1
$206K Buy
+2,264
New +$188K 0.02% 319

Other funds holding GEHC

Plato Investment Management's GEHC Position: Q2 2026 in Review

Plato Investment Management reduced its GE HealthCare (GEHC) stake by 73% in Q2 2026, selling an estimated $505K and leaving 2,773 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #411.

Plato Investment Management first reported a position in GEHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $862K in Q4 2025. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Plato Investment Management held 2,773 shares of GE HealthCare worth $176K as of Q2 2026.
  • Plato Investment Management sold 7,685 GE HealthCare shares in Q2 2026, an estimated $505K.
  • GE HealthCare made up 0.01% of Plato Investment Management's portfolio in Q2 2026, its #411 holding.
  • Plato Investment Management first reported a position in GE HealthCare in Q1 2024 and has held it in 10 quarters since.
  • Plato Investment Management's GE HealthCare position peaked at $862K in Q4 2025.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.